Pharmacological Agents Interacting With Methadone

Information on NAMA’s website is not
intended as medical advice for individual problems. 

 Appropriate medical professionals
should be consulted regarding addiction and addiction recovery.


 

Pharmacologic
Agents

Clinical
Signs
and Symptoms

Comments

Drugs That Decrease Methadone Levels

Rifampin, phenytoin, carbamazepine, butabarbital
sodium, mephobarbital, phenobarbital, secobarbital, ethanol (chronic),
disulfiram, urinary acidifiers, ascorbic acid

Withdrawal signs

Disulfiram may decrease methadone levels but not
significantly. Not clinically problematic.

Drugs That Increase Methadone Levels

Cimetidine, diazepam, ethanol (acute), fluvoxamine
maleate, ketoconazole, urinary alkalinizers

Increased sedation and other opiate effects

Cimetidine can be used in patients with low trough
methadone levels to prolong action (note: must consider cimetidine
effects on other concurrent medications).

Drugs With Levels Affected by Methadone

Desipramine (DMI), zidovudine (AZT)

Possible increased toxicity of DMI and AZT

Methadone descreases DMI and AZT metabolism; may
increase side effects. Close clinical monitoring needed.

Other Opioid and Analgesic Agents

Naltrexone, malmefene,maloxone, buprenorphine,*
butorphanol,* dezocine,* nalbuphine,* pentazocine,* tramadol

Withdrawal signs

 

 

*

Pain-relievers with opioid-antagonist activity.

Synthetic analgesic (not considered opioid
antagonist, but does decrease levels of opiates).

Data from Stine and Kosten,
Addiction Treatment Forum,
Kalvik et al, and Nillson et al.

This chart
courtesy of MedScape

 
The National Alliance Of Methadone Advocates

 

Similar Posts

  • MARYLANDNAMA

    Admin 02/20/2023

    “Together we can make a difference” METHADONE “A life saving medication” Maryland NAMA is the National Alliance of Methadone Advocates (NAMA) official chapter for the state of Maryland. NAMA is a world wide organization dedicated to the betterment of treatment for all methadone patients. Join us in the struggle! NAMA’s Goals To eliminate discrimination toward…

  • DRAFT

    Admin 06/23/2022

    Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office Draft approved for distribution July 2001 THE FEDERATION OF STATE MEDICAL BOARDS OF THE UNITED STATES, INC. Introduction On October 17, 2000, “The Children’s Health Act of 2000” (HR 4365) was signed into federal law. Section 3502 of that Act sets forth the “Drug…

  • Late Breaking News

    Admin 10/18/2022

    New Methadone Regulations The comment period is now over. CSAT has formed a committee to review the comments and the regulations. A short meeting is planned for January 31, 2000. Two NAMA officers are on the committee Lisa Torres, Esq. and Joycelyn Woods. Buprenorphrine Committee A federal committee has been formed to review the guidelines…

  • NAMA Organizational Meeting

    Admin 02/13/2022

    Monday, October 18, 2004 One-By-One Just before the meeting the chapters start strolling in. Walking toward the table Howard Lotsof (NAMA), and standing in the doorway is Sharon Dembinski (NE NAMA-MOM) and Barbara Finger (TexNAMA), Charles Kitts (VA NAMA), Cheri Jarvis (VA NAMA) and Paul Bowman (Boston NAMA) discuss chapter issues, sitting at the end…

  • TRIPS Update

    Admin 08/29/2021

    TRIPS No Longer Operating This past Spring TRIPS the project that assists methadone patients to find an alternative site while traveling was closed. It happened very quickly and as you would expect created problems immediately. NAMA began receiving calls as early as March from patients trying to locate a program in the area that they…

  • References

    Admin 09/12/2022

    Batki, S.L.  Treatment of intravenous drug users with AIDS:  The role of methadone maintenance.  Journal of Psychoactive Drugs 1988 20: 213-216. Legal Action Center. Beazer vs New York City Transit Authority: A Landmark Decision on Methadone Maintenance [Report].  New York: National Institute on Drug Abuse, 1975.   Des Jarlais, D.C.; Friedman, S.R.; Novick, D.M. et…